Abstracts - faqs.org

Abstracts

Business

Search abstracts:
Abstracts » Business

Getting real about valuations in biotech

Article Abstract:

Valuation is the process by which companies and investors assess the worth of their products and programs and is used by companies to guide decisions on project development, licensing negotiations with partners and how equity is divided among investors and management. Valuations of biotech companies and their products are particularly difficult because of the long product development times, high risk of failure and susceptibility of business of changing market conditions.

Author: Villiger, Ralph, Bogdan, Boris
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
Capital funds & cash flow, Valuation

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The new fundamentalism

Article Abstract:

The increasing prominence of 'green activists' who approach the environmental issues in media and political circles is significant cause of concern as it imperils the future of the biotech enterprise and the health of society as a whole. The issue on which the green activists have focused most intensely is the genetic modifications of corp.

Author: Taverne, Dick
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
Health aspects, Environmental aspects, Demonstrations and protests, Environmentalists, Environmental activists, Genetically modified crops

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Fritjof Capra

Article Abstract:

Views of Frijof Capra on the biotech industry are mentioned. According to Capra biotechnology is on the wrong path to achieve its goals.

Author: DeFrancesco, Laura
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
Beliefs, opinions and attitudes, Capra Corp.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Biotechnology industry, Biotechnology industries
Similar abstracts:
  • Abstracts: The S corporation: selling the business on a deferred payment basis. S corporations and their shareholders: the issue of constructive distributions
  • Abstracts: Executing offshore earnings repatriation: Treasury front and center. Earnings management and deferred tax
  • Abstracts: Credit derivatives with multiple debt issues. Rational bubbles or persistent deviations from market fundamentals?
  • Abstracts: Concepts. Square deal: A ceramic outdoor tile freshens the air
  • Abstracts: The regulation of collective investments: the role and responsibilities of a trustee. Cross-country comparisons of efficiency: evidence from the UK and Italian investment firms
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.